TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/05/2025
Back to search
Official data from USPTO
SCT BIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
08/10/2025
Trademark type
Combined
Nice classes
39, 40, 42
Filing date
04/14/2022
Registration date
12/12/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/12/2023
Last transaction
08/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
CZ
Examiner
LUEKEN, ABIGAIL
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized letters "SCT" in red followed by the stylized letters "BIO" in turquoise.
Holders and representatives
Holders
S. S. (pessoa física)
S. A. (pessoa física)
Representatives
Shane Rumbaugh Rumbaugh Law PLLC
Technical classification
Nice Classes
Class 39Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 39
Packaging services in the nature of applications of labels to cell therapy materials; storage and distribution of cell therapy materials
Class 40
Manufacture of cell therapy materialsautologous and allogenic cell-based therapy pharmaceuticals to the order and specification of others; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccinescar-t therapy materialschimeric antigen receptor T cell-based pharmaceuticalstcr-t therapy materialsT cell receptor T cell-based pharmaceuticalscar-nk therapy materialschimeric antigen receptor natural killer cell-based pharmaceuticals to the order and specification of others
Class 42
Pharmaceutical research and developmentfor cell therapy materialscellular vaccinescar-t therapiestcr-t therapiescar-nk therapies; scientific research and developmentfor cell therapy materialscellular vaccinescar-t therapiestcr-t therapiescar-nk therapies; consultation in the field of pharmaceutical research and developmentfor cell therapy materialscellular vaccinescar-t therapiestcr-t therapiescar-nk therapies; product research and developmentfor cell therapy materialscellular vaccinescar-t therapiestcr-t therapiescar-nk therapies; biological materials testing services and biological laboratory servicesfor cell therapy materialscellular vaccinescar-t therapiestcr-t therapiescar-nk therapies; contract research services in the field of cell therapy materialscellular vaccinescar-t therapiestcr-t therapiescar-nk therapies
Publications
History of USPTO decisions and trademark events.
38 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/05/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/02/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/13/2024
FIMP
FINAL DISPOSITION PROCESSED
03/13/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/12/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/16/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/16/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/16/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/12/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/26/2023
PUBO
PUBLISHED FOR OPPOSITION
09/26/2023
GPNX
NOTIFICATION PROCESSED BY IB
09/25/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/06/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/06/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/24/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
08/23/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/23/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
08/23/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/23/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/20/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/20/2023
RFNT
REFUSAL PROCESSED BY IB
02/14/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/25/2023
RFRR
REFUSAL PROCESSED BY MPU
01/25/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/20/2023
CHLD
CHANGE OF OWNER RECEIVED FROM IB
12/25/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/24/2022
CNRT
NON-FINAL ACTION WRITTEN
11/23/2022
DOCK
ASSIGNED TO EXAMINER
11/22/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/18/2022
MAFR
APPLICATION FILING RECEIPT MAILED
08/02/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/29/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/28/2022
Continuous trademark protection
Get notified about every new filing that threatens SCT BIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.